For the year ending 2025-12-31, ATRC made $534,528K in revenue. -$9,847K in net income. Net profit margin of -1.84%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Revenue | 534,528 | |||
| Cost of revenue | 133,749 | |||
| Gross profit | 400,779 | |||
| Research and development expenses | 99,209 | |||
| Selling, general and administrative expenses | 311,017 | |||
| Total operating expenses | 410,226 | |||
| Loss from operations | -9,447 | |||
| Interest expense | 5,878 | |||
| Interest income | 4,479 | |||
| Loss on debt extinguishment | 0 | |||
| Other income (expense) | 683 | |||
| Loss before income tax expense | -10,163 | |||
| Income tax expense | 1,285 | |||
| Net loss | -11,448 | |||
| Unrealized gain on investments | 0 | |||
| Foreign currency translation adjustment | 1,601 | |||
| Other comprehensive income (loss) | 1,601 | |||
| Comprehensive loss, net of tax | -9,847 | |||
| Basic net loss per share (in usd per share) | -0.24 | |||
| Diluted net loss per share (in usd per share) | -0.24 | |||
| Weighted average shares outstanding, basic (in shares) | 47,750,000 | |||
| Weighted average shares outstanding, diluted (in shares) | 47,750,000 | |||
AtriCure, Inc. (ATRC)
AtriCure, Inc. (ATRC)